Search results
An FDA panel just rejected using MDMA to treat PTSD. Here are 5 things to know about the psychedelic...
Yahoo Life Style via AOL· 3 days agoMDMA, also known as ecstasy, is seen by some experts as a potential breakthrough treatment for PTSD,...
... FDA Advisors Reject MDMA For PTSD Treatment - ATAI Life Sciences (NASDAQ:ATAI), Cybin...
Benzinga· 3 days agoA panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for...
Psychedelic stocks tanked after MDMA-assisted therapy for PTSD had a setback
Quartz· 3 days agoDuring regular trading, Mind Medicine, which is developing a form of LSD to treat generalized...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
FOX 5 San Diego· 4 days agoWASHINGTON (AP) — Federal health advisers are weighing the first-of-a-kind approval of MDMA, the...
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By...
Investing.com· 3 days agoMind Medicine (MNMD) fell as much as 13%, COMPASS Pathways plc (CMPS) declined around 10%, and Atai...
Misconduct claims may derail MDMA psychedelic treatment for PTSD
GBH News· 5 days agoPeople with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA. MDMA...
FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD
AOL· 3 days agoIt marked the first time the FDA has considered an illicit psychedelic drug for medical use, but...
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (NASDAQ:CMPS)
Seeking Alpha· 4 days agoA panel of FDA advisors declined to endorse Lykos Therapeutics application for MDMA as a PTSD...